CohBar to Present at the Mitochondria-Targeted Drug Development Summit
14 avr. 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., April 14, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update
30 mars 2021 16h02 HE
|
CohBar, Inc.
MENLO PARK, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Completes Enrollment in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
29 mars 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Announce 2020 Fourth Quarter Financial Results and Provide Business Update on March 30, 2021
16 mars 2021 16h05 HE
|
CohBar, Inc.
MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar Nominates CB5138 Analog as Lead Clinical Candidate for Idiopathic Pulmonary Fibrosis and other Fibrotic Diseases
16 mars 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
12 mars 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at the 33rd Annual ROTH Conference
02 mars 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at the H.C. Wainwright Global Life Sciences Conference
25 févr. 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at the BIO CEO & Investor Digital Conference
09 févr. 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...
CohBar to Present at the 3rd Annual Longevity Therapeutics Conference
20 janv. 2021 09h00 HE
|
CohBar, Inc.
MENLO PARK, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and...